King Fahad Specialist Hospital in Dammam, Saudi Arabia, said it has become the first hospital in the Middle East to offer positron emission mammography services using equipment from Naviscan. "The Middle East, and Saudi Arabia in particular, is poised to be a major growth region for Naviscan. King Fahad is known throughout the Middle East to offer the latest in cutting edge technology and continues to do so with the addition of PEM," Naviscan Chairman and CEO Paul J. Mirabella said.
Naviscan said it has added Dr. Andre Cheng to its board of directors. Cheng formerly was the vice president of Medical Affairs and Reimbursement at Acclarent. "As we expand our global reach and market penetration into new areas of the patient care cycle, adding Andre to our Board will further strengthen Naviscan's already solid reimbursement and clinical impact," Naviscan Chairman and CEO Paul Mirabella said.
UnitedHealthcare's March 1 deadline for accreditation for PET, nuclear medicine and nuclear cardiology at outpatient facilities and doctors' offices has been postponed to the third quarter of this year. The insurer said it will not provide reimbursement unless the procedures are accredited. "Because of its market share, UnitedHealthcare will be viewed as a leader in this respect," said the CEO for the Center for Diagnostic Imaging of Minneapolis.
The rate of thyroid cancer in the U.S. is on the rise, and PET has played a part in increasing detection of residual cancer after surgery, noted the former chief of surgery at University of California, San Francisco, Medical Center, in a university news release.
Patricia A. Woertz, chairman and chief executive of ethanol and food producer Archer Daniels Midland Corp., has been appointed to Procter & Gamble Co.'s board of directors, the company announced Tuesday.